FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225263869> ?p ?o ?g. }

• W4225263869 endingPage "e163" @default.
• W4225263869 startingPage "e163" @default.
• W4225263869 abstract "In Brief Objective: To determine the safety of hepatectomy after combined lenvatinib and anti-PD-1 preoperative systemic therapy (PST) in patients with marginally resectable hepatocellular carcinoma (HCC). Background: PST followed by hepatectomy (PSTH) is an emerging treatment for HCC. However, the impact of PST with lenvatinib plus anti-PD-1 antibodies on surgical safety is unknown. Methods: Medical records from consecutive patients with marginally resectable advanced HCC who underwent hepatectomy after PST with lenvatinib and anti-PD-1 antibodies between January 2018 and August 2021 were retrieved from a prospectively designed database. Propensity score matching (1:2) was performed with a further 2318 HCC patients who underwent upfront hepatectomy (UH) without initial antitumor treatment during the same period. Results: In total, 49 and 98 matched patients were included in the PSTH and UH groups, respectively. Compared to the UH group, individuals in the PSTH group experienced more intraoperative blood loss, blood transfusions, and longer postoperative hospital stays. Moreover, posthepatectomy liver failure was more common in the PSTH group, who also had worse albumin-bilirubin (ALBI) scores on postoperative days 1–7. A significantly greater amount of drainage was also required in the PSTH group. However, the 30-day morbidity and 90-day mortality were similar among the two groups. Additionally, the duration of surgery, use of hepatic inflow occlusion during surgery, and the levels of postoperative inflammation-based markers were not statistically different between the two groups. Conclusions: Despite more intraoperative and postoperative adverse events, PSTH had comparable 30-day morbidity and 90-day mortality as UH. Thus, PSTH appears to be a viable treatment option for marginally resectable HCC patients with careful preoperative evaluation. Mini-abstract: This propensity score-matched study assessed the safety of combined lenvatinib and anti-PD-1 preoperative systemic therapy prior to hepatectomy (PSTH), compared to upfront hepatectomy (UH), in patients with hepatocellular carcinoma. Despite more adverse events in the PSTH group, the 30-day morbidity and 90-day mortality rates were similar for both groups." @default.
• W4225263869 created "2022-05-04" @default.
• W4225263869 creator A5002708668 @default.
• W4225263869 creator A5010519360 @default.
• W4225263869 creator A5017352295 @default.
• W4225263869 creator A5029634246 @default.
• W4225263869 creator A5031371726 @default.
• W4225263869 creator A5038545320 @default.
• W4225263869 creator A5039470373 @default.
• W4225263869 creator A5042464922 @default.
• W4225263869 creator A5066029512 @default.
• W4225263869 date "2022-05-02" @default.
• W4225263869 modified "2023-10-18" @default.
• W4225263869 title "The Safety Profile of Hepatectomy Following Preoperative Systemic Therapy with Lenvatinib Plus Anti-PD-1 Antibodies Versus Hepatectomy Alone in Patients With Hepatocellular Carcinoma" @default.
• W4225263869 cites W1537030048 @default.
• W4225263869 cites W1755620415 @default.
• W4225263869 cites W1971837077 @default.
• W4225263869 cites W1975010709 @default.
• W4225263869 cites W2016491365 @default.
• W4225263869 cites W2019607817 @default.
• W4225263869 cites W2028319026 @default.
• W4225263869 cites W2052568563 @default.
• W4225263869 cites W2059525132 @default.
• W4225263869 cites W2092679286 @default.
• W4225263869 cites W2096998881 @default.
• W4225263869 cites W2107934474 @default.
• W4225263869 cites W2119190881 @default.
• W4225263869 cites W2137869551 @default.
• W4225263869 cites W2151600653 @default.
• W4225263869 cites W2297393465 @default.
• W4225263869 cites W2409444907 @default.
• W4225263869 cites W2591717879 @default.
• W4225263869 cites W2596787305 @default.
• W4225263869 cites W2625856057 @default.
• W4225263869 cites W2787358630 @default.
• W4225263869 cites W2938801248 @default.
• W4225263869 cites W2968110036 @default.
• W4225263869 cites W2977722669 @default.
• W4225263869 cites W2990602950 @default.
• W4225263869 cites W3007074770 @default.
• W4225263869 cites W3008514541 @default.
• W4225263869 cites W3025022288 @default.
• W4225263869 cites W3042677173 @default.
• W4225263869 cites W3045387409 @default.
• W4225263869 cites W3091894087 @default.
• W4225263869 cites W3093964219 @default.
• W4225263869 cites W3099108820 @default.
• W4225263869 cites W3114582868 @default.
• W4225263869 cites W3121026211 @default.
• W4225263869 cites W3134314411 @default.
• W4225263869 cites W3149900842 @default.
• W4225263869 cites W3154623755 @default.
• W4225263869 cites W3171790682 @default.
• W4225263869 cites W3176321144 @default.
• W4225263869 cites W3186127018 @default.
• W4225263869 cites W3208308450 @default.
• W4225263869 cites W3212963169 @default.
• W4225263869 doi "https://doi.org/10.1097/as9.0000000000000163" @default.
• W4225263869 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37601608" @default.
• W4225263869 hasPublicationYear "2022" @default.
• W4225263869 type Work @default.
• W4225263869 citedByCount "3" @default.
• W4225263869 countsByYear W42252638692022 @default.
• W4225263869 countsByYear W42252638692023 @default.
• W4225263869 crossrefType "journal-article" @default.
• W4225263869 hasAuthorship W4225263869A5002708668 @default.
• W4225263869 hasAuthorship W4225263869A5010519360 @default.
• W4225263869 hasAuthorship W4225263869A5017352295 @default.
• W4225263869 hasAuthorship W4225263869A5029634246 @default.
• W4225263869 hasAuthorship W4225263869A5031371726 @default.
• W4225263869 hasAuthorship W4225263869A5038545320 @default.
• W4225263869 hasAuthorship W4225263869A5039470373 @default.
• W4225263869 hasAuthorship W4225263869A5042464922 @default.
• W4225263869 hasAuthorship W4225263869A5066029512 @default.
• W4225263869 hasBestOaLocation W42252638691 @default.
• W4225263869 hasConcept C126322002 @default.
• W4225263869 hasConcept C141071460 @default.
• W4225263869 hasConcept C159110652 @default.
• W4225263869 hasConcept C197934379 @default.
• W4225263869 hasConcept C2776264508 @default.
• W4225263869 hasConcept C2776909242 @default.
• W4225263869 hasConcept C2778019345 @default.
• W4225263869 hasConcept C2778695046 @default.
• W4225263869 hasConcept C71924100 @default.
• W4225263869 hasConcept C90924648 @default.
• W4225263869 hasConceptScore W4225263869C126322002 @default.
• W4225263869 hasConceptScore W4225263869C141071460 @default.
• W4225263869 hasConceptScore W4225263869C159110652 @default.
• W4225263869 hasConceptScore W4225263869C197934379 @default.
• W4225263869 hasConceptScore W4225263869C2776264508 @default.
• W4225263869 hasConceptScore W4225263869C2776909242 @default.
• W4225263869 hasConceptScore W4225263869C2778019345 @default.
• W4225263869 hasConceptScore W4225263869C2778695046 @default.
• W4225263869 hasConceptScore W4225263869C71924100 @default.
• W4225263869 hasConceptScore W4225263869C90924648 @default.
• W4225263869 hasIssue "2" @default.
• W4225263869 hasLocation W42252638691 @default.
• W4225263869 hasLocation W42252638692 @default.

• next